Tag

Sunil Chari

2 articles

Rossari Biotech Q4 FY26 Revenue Hits Record ₹684.9 Crore

Rossari Biotech reported record Q4 FY26 revenue of ₹684.9 crore, up 18.2% YoY, with PAT growing 33.7% to ₹46.0 crore. The company commissioned 15,000 MTPA ethoxylation capacity at Dahej, taking total

Rossari Biotech Q4 Net Profit Up 34% YoY

Rossari Biotech announced Q4 FY26 results with revenue up 18% YoY to Rs. 684.9 crore and PAT up 34% to Rs. 46.0 crore. EBITDA increased 11% to Rs. 77.3 crore, while margin was 11.3% vs 12.0% last year